Prescribing statins

Editorial

J K Aronson. Br J Clin Pharmacol. 2005 Nov.

. 2005 Nov;60(5):457-8.

doi: 10.1111/j.1365-2125.2005.02521.x.

No abstract available

Comment on

General practitioners' adoption of new drugs and previous prescribing of drugs belonging to the same therapeutic class: a pharmacoepidemiological study.
Dybdahl T, Andersen M, Kragstrup J, Kristiansen IS, Søndergaard J. Dybdahl T, et al. Br J Clin Pharmacol. 2005 Nov;60(5):526-33. doi: 10.1111/j.1365-2125.2005.02463.x. Br J Clin Pharmacol. 2005. PMID: 16236043 Free PMC article.
Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003.
Walley T, Folino-Gallo P, Stephens P, Van Ganse E. Walley T, et al. Br J Clin Pharmacol. 2005 Nov;60(5):543-51. doi: 10.1111/j.1365-2125.2005.02478.x. Br J Clin Pharmacol. 2005. PMID: 16236045 Free PMC article.

1. Aronson JK. Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions. J Eval Clin Pract. 2005;11:195–208. - PubMed
1. Aronson JK. Rational prescribing, appropriate prescribing. Br J Clin Pharmacol. 2004;57:229–30. - PMC - PubMed
1. Aronson JK. Over-the-counter medicines. Br J Clin Pharmacol. 2004;58:231–4. - PMC - PubMed
1. Olsson AG, Molgaard J, Von Schenk H. Synvinolin in hypercholesterolaemia. Lancet. 1986;2:390–1. - PubMed
1. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80% Br Med J. 2003;326:1419–22. - PMC - PubMed